These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19570000)

  • 1. Subcutaneous bioavailability of a PRIMATIZED IgG1 anti-human CD4 monoclonal antibody is dose dependent in transgenic mice bearing human CD4.
    Davis CB; Bugelski PJ
    Drug Deliv; 1998; 5(2):95-100. PubMed ID: 19570000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
    Davis CB; Garver EM; Kwok DC; Urbanski JJ
    Drug Metab Dispos; 1996 Sep; 24(9):1032-7. PubMed ID: 8886616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4.
    Anderson D; Chambers K; Hanna N; Leonard J; Reff M; Newman R; Baldoni J; Dunleavy D; Reddy M; Sweet R; Truneh A
    Clin Immunol Immunopathol; 1997 Jul; 84(1):73-84. PubMed ID: 9191886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial.
    Yocum DE; Solinger AM; Tesser J; Gluck O; Cornett M; O'Sullivan F; Nordensson K; Dallaire B; Shen CD; Lipani J
    J Rheumatol; 1998 Jul; 25(7):1257-62. PubMed ID: 9676753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4.
    Sharma A; Davis CB; Tobia LA; Kwok DC; Tucci MG; Gore ER; Herzyk DJ; Hart TK
    J Pharmacol Exp Ther; 2000 Apr; 293(1):33-41. PubMed ID: 10734150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
    Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
    Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of monoclonal antibody delivery via the lymphatics: the dose dependence.
    Steller MA; Parker RJ; Covell DG; Holton OD; Keenan AM; Sieber SM; Weinstein JN
    Cancer Res; 1986 Apr; 46(4 Pt 1):1830-4. PubMed ID: 3948166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
    Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
    J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of administration of a human anti-CD4 monoclonal antibody, HM6G, in nonhuman primates.
    Fishwild DM; Hudson DV; Deshpande U; Kung AH
    Clin Immunol; 1999 Aug; 92(2):138-52. PubMed ID: 10444358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody.
    Chirmule N; Truneh A; Haecker SE; Tazelaar J; Gao Gp; Raper SE; Hughes JV; Wilson JM
    J Immunol; 1999 Jul; 163(1):448-55. PubMed ID: 10384148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis.
    Mould DR; Davis CB; Minthorn EA; Kwok DC; Elliott MJ; Luggen ME; Totoritis MC
    Clin Pharmacol Ther; 1999 Sep; 66(3):246-57. PubMed ID: 10511060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
    Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimaeric anti-CD4 monoclonal antibody cross-linked by monocyte Fc gamma receptor mediates apoptosis of human CD4 lymphocytes.
    Choy EH; Adjaye J; Forrest L; Kingsley GH; Panayi GS
    Eur J Immunol; 1993 Oct; 23(10):2676-81. PubMed ID: 8104799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level expression and characterization of a mouse-human chimeric CD4 antibody with therapeutic potential.
    Looney JE; Knight DM; Arevalo-Moore M; Trinh H; Pak KY; Dalesandro MR; Rieber EP; Riethmuller G; Daddona PE; Ghrayeb J
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):191-200. PubMed ID: 1477300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
    de Kroon JF; de Paus RA; Kluin-Nelemans HC; Kluin PM; van Bergen CA; Munro AJ; Hale G; Willemze R; Falkenburg JH
    Exp Hematol; 1996 Jul; 24(8):919-26. PubMed ID: 8690051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.